GeoVax Total Assets from 2010 to 2025

GOVX Stock

USD 1.44 0.04 2.70%

GeoVax Labs Total Assets yearly trend continues to be fairly stable with very little volatility. Total Assets are likely to outpace its year average in 2025. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2000-03-31

Previous Quarter

4.1 M

Current Value

11.1 M

Quarterly Volatility

7.8 M

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check GeoVax Labs financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among GeoVax Labs' main balance sheet or income statement drivers, such as Depreciation And Amortization of 63.4 K, Interest Expense of 48.6 K or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 205, Dividend Yield of 0.0 or PTB Ratio of 2.61. GeoVax financial statements analysis is a perfect complement when working with GeoVax Labs Valuation or Volatility modules.

Check out the analysis of GeoVax Labs Correlation against competitors.

For more information on how to buy GeoVax Stock please use our How to Invest in GeoVax Labs guide.

Latest GeoVax Labs' Total Assets Growth Pattern

Below is the plot of the Total Assets of GeoVax Labs over the last few years. Total assets refers to the total amount of GeoVax Labs assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in GeoVax Labs books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. GeoVax Labs' Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in GeoVax Labs' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 9.28 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

GeoVax Total Assets Regression Statistics

	Arithmetic Mean	6,184,317
	Geometric Mean	2,820,478
	Coefficient Of Variation	130.24
	Mean Deviation	5,950,188
	Median	2,839,576
	Standard Deviation	8,054,395
	Sample Variance	64.9T
	Range	30.9M
	R-Value	0.60
	Mean Square Error	44.1T
	R-Squared	0.37
	Significance	0.01
	Slope	1,022,377
	Total Sum of Squares	973.1T

GeoVax Total Assets History

	2025	11.2 M
	2024	10.7 M
	2023	9.3 M
	2022	31.3 M
	2021	11.8 M
	2020	10.4 M
	2019	468.9 K

Other Fundumenentals of GeoVax Labs

Intangibles To Total Assets

GeoVax Labs Total Assets component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Common Stock	Good Will	Short Term Debt	Long Term Debt	Intangible Assets	Property Plant Equipment	Current Deferred Revenue	Net Tangible Assets	Net Invested Capital	Net Working Capital	Short Long Term Debt	Capital Stock	Capital Surpluse
Total Assets		0.97	-0.98	-0.65	0.6	-0.26	0.66	1.0	-0.3	0.15	-0.27	-0.49	-0.09	0.07	0.1	0.73	0.98	0.98	-0.31	-0.78	-0.22
Total Stockholder Equity	0.97		-0.96	-0.53	0.46	-0.18	0.48	0.97	-0.28	0.08	-0.19	-0.39	-0.04	0.11	0.05	0.67	0.98	0.98	-0.2	-0.67	-0.14
Net Debt	-0.98	-0.96		0.55	-0.47	0.19	-0.66	-0.99	0.27	-0.16	0.22	0.5	0.16	0.02	-0.16	-0.59	-0.97	-0.98	0.26	0.72	0.05
Retained Earnings	-0.65	-0.53	0.55		-0.94	0.44	-0.7	-0.62	0.27	-0.43	0.41	0.7	0.29	0.13	-0.31	-0.9	-0.64	-0.57	0.53	0.88	0.55
Accounts Payable	0.6	0.46	-0.47	-0.94		-0.43	0.69	0.57	-0.38	0.35	-0.37	-0.58	-0.15	0.02	0.18	0.91	0.55	0.49	-0.46	-0.85	-0.71
Net Receivables	-0.26	-0.18	0.19	0.44	-0.43		-0.38	-0.25	0.02	0.24	0.38	-0.07	-0.34	-0.37	0.32	-0.32	-0.2	-0.19	0.28	0.28	0.26
Total Liab	0.66	0.48	-0.66	-0.7	0.69	-0.38		0.67	-0.21	0.24	-0.4	-0.56	-0.2	-0.08	0.25	0.5	0.58	0.58	-0.44	-0.75	-0.15
Total Current Assets	1.0	0.97	-0.99	-0.62	0.57	-0.25	0.67		-0.3	0.13	-0.27	-0.48	-0.09	0.07	0.09	0.69	0.98	0.99	-0.3	-0.77	-0.18
Common Stock	-0.3	-0.28	0.27	0.27	-0.38	0.02	-0.21	-0.3		-0.05	0.43	0.25	-0.02	-0.15	0.01	-0.41	-0.27	-0.26	0.43	0.43	0.23
Good Will	0.15	0.08	-0.16	-0.43	0.35	0.24	0.24	0.13	-0.05		0.06	-0.88	-0.96	-0.91	0.93	0.32	0.2	0.18	-0.28	-0.33	-0.36
Short Term Debt	-0.27	-0.19	0.22	0.41	-0.37	0.38	-0.4	-0.27	0.43	0.06		0.23	-0.14	-0.17	0.13	-0.3	-0.24	-0.22	0.94	0.43	0.26
Long Term Debt	-0.49	-0.39	0.5	0.7	-0.58	-0.07	-0.56	-0.48	0.25	-0.88	0.23		0.83	0.72	-0.82	-0.56	-0.53	-0.5	0.51	0.7	0.34
Intangible Assets	-0.09	-0.04	0.16	0.29	-0.15	-0.34	-0.2	-0.09	-0.02	-0.96	-0.14	0.83		0.98	-0.97	-0.14	-0.15	-0.14	0.19	0.21	0.09
Property Plant Equipment	0.07	0.11	0.02	0.13	0.02	-0.37	-0.08	0.07	-0.15	-0.91	-0.17	0.72	0.98		-0.94	0.06	0.01	0.01	0.14	0.03	-0.01
Current Deferred Revenue	0.1	0.05	-0.16	-0.31	0.18	0.32	0.25	0.09	0.01	0.93	0.13	-0.82	-0.97	-0.94		0.16	0.16	0.13	-0.17	-0.22	-0.05
Net Tangible Assets	0.73	0.67	-0.59	-0.9	0.91	-0.32	0.5	0.69	-0.41	0.32	-0.3	-0.56	-0.14	0.06	0.16		0.73	0.66	-0.4	-0.85	-0.67
Net Invested Capital	0.98	0.98	-0.97	-0.64	0.55	-0.2	0.58	0.98	-0.27	0.2	-0.24	-0.53	-0.15	0.01	0.16	0.73		0.99	-0.3	-0.78	-0.19
Net Working Capital	0.98	0.98	-0.98	-0.57	0.49	-0.19	0.58	0.99	-0.26	0.18	-0.22	-0.5	-0.14	0.01	0.13	0.66	0.99		-0.28	-0.74	-0.16
Short Long Term Debt	-0.31	-0.2	0.26	0.53	-0.46	0.28	-0.44	-0.3	0.43	-0.28	0.94	0.51	0.19	0.14	-0.17	-0.4	-0.3	-0.28		0.52	0.39
Capital Stock	-0.78	-0.67	0.72	0.88	-0.85	0.28	-0.75	-0.77	0.43	-0.33	0.43	0.7	0.21	0.03	-0.22	-0.85	-0.78	-0.74	0.52		0.46
Capital Surpluse	-0.22	-0.14	0.05	0.55	-0.71	0.26	-0.15	-0.18	0.23	-0.36	0.26	0.34	0.09	-0.01	-0.05	-0.67	-0.19	-0.16	0.39	0.46

Click cells to compare fundamentals

About GeoVax Labs Financial Statements

GeoVax Labs investors use historical fundamental indicators, such as GeoVax Labs' Total Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in GeoVax Labs. Please read more on our technical analysis and fundamental analysis pages.

		Last Reported	Projected for Next Year
	Total Assets	10.7 M	11.2 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

CRM	Salesforce
C	Citigroup
GM	General Motors

Additional Tools for GeoVax Stock Analysis

When running GeoVax Labs' price analysis, check to measure GeoVax Labs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeoVax Labs is operating at the current time. Most of GeoVax Labs' value examination focuses on studying past and present price action to predict the probability of GeoVax Labs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeoVax Labs' price. Additionally, you may evaluate how the addition of GeoVax Labs to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC